co.don AG
CNW | F
Overview
Corporate Details
- ISIN(s):
- DE000A3E5C08 (+1 more)
- LEI:
- 3912006R73YW0SX1KG21
- Country:
- Germany
- Address:
- Warthestr. 21, 14513 Teltow
- Website:
- https://www.codon.de/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
co.don AG is a biopharmaceutical company specializing in tissue engineering and regenerative medicine. The company focuses on the development, manufacturing, and marketing of autologous cell therapies for the treatment of articular cartilage defects. Its core process involves using a patient's own cartilage cells (chondrocytes) to produce personalized cell transplants, such as spherical cartilage cell implants (spheroids), for the minimally invasive repair of joints. Following an asset purchase in early 2023, the operative business was taken over by an investor and now operates as CO.DON GmbH, a ReLive company, continuing its work in human cell-based therapies.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for co.don AG.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2022-09-30 00:00 |
Interim Report
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2022 bis zum 30.0…
|
German | 142.4 KB | |
| 2022-09-29 00:00 |
Report Publication Announcement
Hinweis auf Halbjahresfinanzbericht vom 01.01.2022 bis zum 30.06.2022
|
German | 6.4 KB | |
| 2022-07-11 00:00 |
Regulatory News Service
Jahres- und Konzernabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
|
German | 1.3 MB | |
| 2022-07-06 00:00 |
Regulatory News Service
Berichtigung der Veröffentlichung vom 14.06.2022
|
German | 6.4 KB | |
| 2022-06-14 00:00 |
Report Publication Announcement
Berichtigt am 06.07.2022
|
German | 6.4 KB | |
| 2022-04-29 00:00 |
Report Publication Announcement
Hinweis auf Jahresfinanzbericht vom 01.01.2021 bis zum 31.12.2021
|
German | 6.4 KB | |
| 2021-09-11 00:00 |
Director's Dealing
CO.DON AG: Mitteilung über Eigengeschäfte von Führungskräften gem. Art. 19 MAR
|
German | 13.9 KB | |
| 2021-08-30 00:00 |
Interim Report
Halbjahresfinanzbericht
|
German | 148.6 KB | |
| 2021-05-27 00:00 |
Report Publication Announcement
Jahresabschluss zum Geschäftsjahr vom 01.01.2020 bis zum 31.12.2020
|
German | 4.2 KB | |
| 2021-05-25 00:00 |
Annual Report
Konzernabschluss zum Geschäftsjahr vom 01.01.2020 bis zum 31.12.2020
|
German | 4.2 KB | |
| 2021-05-22 00:00 |
Regulatory News Service
Ad-hoc-Meldung gemäß Art. 17 MAR in Verbindung mit § 4 Abs. 1 S. 1 Nr. 1a WpAV
|
English | 11.8 KB |
Automate Your Workflow. Get a real-time feed of all co.don AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for co.don AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2021-10-21 | Günther, Bernd | Supervisory board | Buy | None | 35.84 EUR |
| 2021-10-20 | Laik, Robin | Board | Other | None | 10,348,300.00 EUR |
| 2021-10-20 | ELBER GmbH | Close relation | Other | None | 10,179,000.00 EUR |
| 2021-10-20 | Rofalski, Volker | Supervisory board | Other | None | 292,500.00 EUR |
| 2021-10-20 | Müller, Dr. Axel | Supervisory board | Other | None | 195,000.00 EUR |
| 2021-10-20 | Laumann, Johannes | Board | Other | None | 131,625.00 EUR |
| 2021-10-20 | Laik, Louisa | Close relation | Other | None | 129,987.00 EUR |
| 2021-10-20 | Laik, Daniel | Close relation | Other | None | 97,500.00 EUR |
| 2021-10-20 | Friedrich, Neela | Close relation | Other | None | 64,993.50 EUR |
| 2021-10-20 | Schleede, Dr. Kristian | Board | Other | None | 29,250.00 EUR |
